Prot# 2-001: A Randomized, Double-Blind, Placebo-Controlled, Phase-2B Study to Assess the Safety and Efficacy Effects of ART-123 on Subjects with Sepsis and Disseminated Intravascular Coagulation

Project: Research project

Project Details

StatusFinished
Effective start/end date9/5/07 → 9/5/10

Funding

  • Asahi Kasei Pharma America Corp. (2-001)